pfizer glp-1 agonist Is Going All In on Drugs Through China Sciwind Biosciences partners with Pfizer
Description
The airball comes as Novo scrambles to regain a majority share of the GLP-1 market.
No injections
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).
SKU: INNO-GLP1SHRED-STK
Compounded GLP-1 + B12 is a powerful, customized formula designed to enhance weight loss, regulate blood sugar, and boost energy levels
Within the first seven days, youll feel it working!*
